Cabot's Q3 fiscal 2026 earnings beat estimates as Performance Chemicals gains offset Reinforcement Materials margin pressure.
Cabot NYSE: CBT reported third-quarter fiscal 2026 adjusted earnings per share of $1.67, up 4% sequentially, as strength in its Performance Chemicals segment helped offset lower earnings in Reinforcement Materials.
Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT's disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures.
| Specialty Retail Industry | Consumer Discretionary Sector | Sean D. Keohane CEO | XFRA Exchange | 127055101 CUSIP |
| US Country | 4,064 Employees | 28 Aug 2026 Last Dividend | 25 Mar 1996 Last Split | 5 Nov 1980 IPO Date |
Cabot Corporation is a global leader in specialty chemicals and performance materials with a rich history dating back to 1882. Based in Boston, Massachusetts, the company thrives on innovation and technology-driven solutions. Operating through two major segments, Reinforcement Materials and Performance Chemicals, Cabot Corporation caters to a diverse range of industries worldwide. Its products play critical roles in rubber reinforcement, performance additives, electronic components, coatings, and many other applications across the automotive, industrial, consumer goods, and electronics markets. With a robust sales network spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific, the company effectively distributes its products globally, ensuring they meet various customer needs across different sectors.
The array of products and services offered by Cabot Corporation is extensive, catering to various needs across different industries with high-quality materials and innovative solutions.